PolyMedix Launches New Website
December 06, 2011 09:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Dec. 6, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTC BB:PYMX), a clinical-stage biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious...
PolyMedix to Present at the Lazard Healthcare Conference
November 08, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Nov. 8, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute...
PolyMedix Presents PMX-30063 Antibiotic Data at the 49th Annual Meeting of the Infectious Disease Society of America
October 24, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Oct. 24, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a clinical stage biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders...
Stephen T. Sonis, DMD, DMSc Joins PolyMedix's Research Scientific Advisory Board
October 11, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Oct. 11, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), a biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute...
PolyMedix Selected as Best Mid-Stage Product Development Company at Annual Life Sciences Awards
October 06, 2011 09:11 ET
|
PolyMedix, Inc.
RADNOR, Pa., Oct. 6, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and...
PolyMedix Initiates Phase 1B/2 Dose-Response Clinical Trial to Reverse the Anticoagulant Activity of Enoxaparin with PMX-60056
September 27, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Sept. 27, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and...
PolyMedix Presents Antibiotic Data in Oral Session at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
September 19, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Sept. 19, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and...
PolyMedix to Present at the UBS Global Life Sciences Conference
September 13, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Sept. 13, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and...
PolyMedix Provides Updates on Lead Clinical Programs
September 12, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Sept. 12, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and...
PolyMedix to Present at the Rodman and Renshaw Global Investment Conference
September 06, 2011 07:00 ET
|
PolyMedix, Inc.
RADNOR, Pa., Sept. 6, 2011 (GLOBE NEWSWIRE) -- PolyMedix, Inc. (OTCBB:PYMX), an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and...